![](/img/cover-not-exists.png)
Cost-effectiveness of capecitabine and bevacizumab maintenance treatment after first-line induction treatment in metastatic colorectal cancer
Franken, M.D., van Rooijen, E.M., May, A.M., Koffijberg, H., van Tinteren, H., Mol, L., ten Tije, A.J., Creemers, G.J., van der Velden, A.M.T., Tanis, B.C., Uyl-de Groot, C.A., Punt, C.J.A., Koopman,Volume:
75
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/j.ejca.2017.01.019
Date:
April, 2017
File:
PDF, 496 KB
english, 2017